Skip to main content

What do you think about our new look?

We've revamped our site to make it snappier, more accessible, and with an improved look and feel. Please let us know how we can serve you better. Give feedback

Ministry of Health
  1. Home
  2. Newsroom
  3. START OF NUVAXOVID COVID-19 VACCINATION AND JOINT TESTING VACCINATION CENTRE OPERATIONS
Press Releases

START OF NUVAXOVID COVID-19 VACCINATION AND JOINT TESTING VACCINATION CENTRE OPERATIONS

13 May 2022

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

        Starting today, individuals aged 18 years and above who are recommended to receive COVID-19 vaccination, including boosters, may book an appointment to receive the Nuvaxovid COVID-19 vaccine (Nuvaxovid) by Novavax at the Joint Testing and Vaccination Centre (JTVC) Bishan (former Bishan Park Secondary School), or any of the 20 participating Public Health Preparedness Clinics (PHPCs). The PHPCs will commence Nuvaxovid vaccination from 18 May 2022, while the JTVC Bishan will commence vaccination services from 24 May 2022. 

2.     The JTVC Bishan is one of five JTVCs, a new class of facility offering both COVID-19 testing and vaccination services, which will begin operations from 24 May 2022. The list of JTVCs and participating PHPCs can be found at www.vaccine.gov.sg/locations. 

Joint Testing and Vaccination Centres 

3.     As of 12 May 2022, 92% of our total population have completed their primary vaccination series and 75% have received their booster doses. With good vaccination coverage and the majority of our total population well-protected, we will be progressively stepping down the number of Vaccination Centres (VCs) from end-May 2022, as previously announced on 22 April 2022. 

4.     To ensure that COVID-19 testing and vaccination services remain accessible to the general public, we will be establishing a first tranche of five JTVCs on 24 May 2022, with another five JTVCs opening progressively across the island from end-June 2022. These centres are designed with the ability to scale up operations in the event of an emerging Variant of Concern in future.  

5.     To enable the medical service providers to better manage vaccine preparation and reduce any unnecessary wastage, the public are strongly encouraged to book an appointment via the National Appointment System before proceeding to the JTVCs. Please refer to Annex A for the list of the JTVCs. 

Rollout of Nuvaxovid Vaccination

6.     Persons who have yet to take a dose of any COVID-19 vaccine and wish to receive Nuvaxovid for their primary vaccination series may register their interest at vaccine.gov.sg from today. An SMS with a personalised booking link will be sent to the registered mobile number to book an appointment on the National Appointment System. Those with an existing SMS to book an appointment may use the booking link in that SMS to book their Nuvaxovid vaccination appointments. 

7.     As recommended by the Expert Committee on COVID-19 Vaccination, individuals aged 18 years and above may receive the Nuvaxovid vaccine for their primary series or booster vaccination, although the mRNA vaccines remain the preferred vaccines due to their higher efficacy and the stronger immune response generated. Those who are medically ineligible to receive the mRNA vaccines should consider the Nuvaxovid. Under the National Vaccination Programme, the Sinovac-Coronvac vaccine will only be made available as a booster to persons who are medically ineligible1 to receive the mRNA vaccines and Nuvaxovid. Persons receiving Nuvaxovid for their primary vaccination series are recommended to receive two doses at least 21 days apart. Those receiving Nuvaxovid for their first or second booster dose are recommended to receive it from about five months after their last dose. 

8.     Persons aged 18 and above will need to be medically ineligible to mRNA, Nuvaxovid and Sinovac-CoronaVac COVID-19 vaccines to be considered medically ineligible for COVID-19 vaccination in Singapore and exempted from Vaccination-Differentiated Safe Management Measures. 

9.     Individuals who are currently medically ineligible for mRNA and Sinovac-CoronaVac would need to complete their vaccination with Nuvaxovid or be reassessed as medically ineligible to all COVID-19 vaccines under the National Vaccination Programme by their doctors to maintain their vaccination status. The validity of medical ineligibility memos issued before 1 June 2022 will expire on 1 August 2022. Medical ineligibility memos issued on 1 June 2022 onwards will be valid and required for these individuals to maintain their vaccination status past 1 August 2022.

10.     Boosters and vaccinations remain a critical part of our COVID-19 strategy in ensuring our population is well-protected against infection and severe illness. We urge all who are eligible for vaccinations and booster doses to receive them as soon as possible.


MINISTRY OF HEALTH
13 MAY 2022


1 Individuals who are medically ineligible for mRNA COVID-19 vaccines include those who developed anaphylaxis/severe allergic reactions or myocarditis/pericarditis to a previous dose of any mRNA vaccine. Individuals who are medically ineligible for Nuvaxovid include those who had anaphylaxis/severe allergic reactions to a previous dose of the vaccine, or to any ingredients in the vaccine.